More on 'universal'versus'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis

Comment

Emmanuel J Favaloro. Br J Haematol. 2006 Jul.

. 2006 Jul;134(2):239-40; author reply 241.

doi: 10.1111/j.1365-2141.2006.06138.x.

No abstract available

Comment on

Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.
Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Walker I, Brenkel I, Greaves M, Langhorne P, Regan L, Greer I; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Wu O, et al. Br J Haematol. 2005 Oct;131(1):80-90. doi: 10.1111/j.1365-2141.2005.05715.x. Br J Haematol. 2005. PMID: 16173967
Universal or selected screening for thrombophilia.
Keeling D. Keeling D. Br J Haematol. 2006 Apr;133(1):106-7. doi: 10.1111/j.1365-2141.2006.06005.x. Br J Haematol. 2006. PMID: 16512838 No abstract available.